Navigation Links
Coronary artery stenting viable palliative option for infants and toddlers
Date:8/21/2011

Percutaneous coronary intervention (PCI) is not a generally accepted option for infants or toddlers with acute coronary syndrome. However, a new report published in the August issue of Catheterization and Cardiovascular Interventions, a journal of The Society for Cardiovascular Angiography and Interventions (SCAI), found coronary stent implantation to be a feasible and safe palliative option for children fifteen months and younger.

Studies have shown that in adults with reduced blood flow to the heartknown as acute coronary syndrome (ACS)stent implantation significantly reduces mortality. While ACS is less common in children there are congenital and acquired heart disease that may compromise coronary circulation in the pediatric population. Due to increased risk of coronary interventions and difficulty of cardiac catheterization techniques in pediatric patients, PCI is not a recommended treatment strategy in this age group.

A research team led by Dr. Andrs Bratincsk from Rady Children's Hospital in San Diego, California, conducted a retrospective review of seven children who had PCI between June 2006 and June 2010. Of those included in the study all were under 18 years of age and four were 15 months or younger. PCI techniques included balloon coronary angioplasty and coronary stent implantation. Researchers analyzed patient data that included underlying diagnosis, comorbidites, catheterization technique, and outcomes.

In all seven cases, successful stent placement in the proximal portion of the left or right coronary arteries with excellent revascularization was achieved. The average diameter of the heart arteries was 0.65 mm prior to the intervention. Balloon angioplasty did not completely resolve the stenosis and bare metal stents were then implanted to a mean internal diameter of 2.5 mm. The team determined that the average intervention-free period was 434 days after stent implantation. Restenosis and thrombosis did not occur in cases where the implanted stent diameter was greater than 2.5 mm and patients received dual anti-platelet therapy.

"We provide evidence that stent implantation is a relatively safe option for pediatric patients with coronary stenosis, including those under the age of 15 months," said Dr. Bratincsk. "PCI offers a viable strategy for bridging infants and toddlers with blocked arteries or poor ventricular function to surgical revascularization or transplantation when they are at an older age."


'/>"/>

Contact: Dawn Peters
healthnews@wiley.com
781-388-8408
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Fat around heart may be early indicator of coronary disease
2. Predicting perilous plaque in coronary arteries via fluid dynamics
3. Coronary heart disease goes unrecognized
4. High-resolution imaging technology reveals cellular details of coronary arteries
5. Positive results for unprotected left main coronary artery PCI with drug-eluting stents
6. Potential new treatment to reduce the burden of atherosclerosis in acute coronary syndrome patients
7. Clots in Coronary Stents More Likely in Early Morning
8. DMP for coronary heart disease: Current guidelines indicate some need for revision
9. Coronary imaging enhances ability to identify plaques likely to cause future heart disease
10. CTO summit and left main coronary interventions course will feature latest research and techniques
11. CTO Summit & Left Main Coronary Interventions Course to be held Feb. 14-16, 2011, in NYC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... ... with an Award of Distinction, recognizing the organization as a top behavioral service ... in the areas of clinical quality, staff satisfaction and qualifications, and consumer satisfaction. ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... fields in research and development, largely due to its potential for revolutionizing human ... cells (hMSCs) and human induced pluripotent stem cells (hiPSCs). , Both platforms ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... a one-stop portal for all the knowledge resources, including white papers, guides, handbooks, ... and more. , To access more than 9,000 documents, webinars and videos ...
(Date:12/6/2016)... ... ... 'Tis the season for family, festivity, food and fun! Temptation abounds, and ... eating healthy, staying active, and taking medication and doing daily foot health checks (a ... "Shopping trips, parties and family gatherings can take their toll on our feet during ...
(Date:12/6/2016)... ... December 06, 2016 , ... Specialty Technical ... updated International Audit Protocol Consortium (IAPC) EHS audit protocol for Great Britain ... the scope of their EHS regulatory obligations and rapidly collect, share, archive, and ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016 Sangamo BioSciences, Inc. (Nasdaq: ... announced the presentation of preclinical and manufacturing data that support ... 58 th Annual Meeting of the American Society of ... , from December 3-6, 2016. "We have ... A which we believe is highly competitive, and we remain ...
(Date:12/5/2016)... Dec. 5, 2016  Parallax Health Sciences, Inc. ("Parallax" ... announce that its pharmaceutical business, RoxSan Pharmacy, Inc. has ... coverage in all of the 42 states it is ... Michael Rashti Pharm . D, Pharmacist in Charge ... for our business. Medicare B spending last year came ...
(Date:12/5/2016)... BOCA RATON, Fla. , Dec. ... the Commercialization of Public Research (the Florida ... funding agreement SegAna, LLC, an Orlando ... of Central Florida. The Florida Institute supports new ... early funding gaps for companies spinning out of Florida-based ...
Breaking Medicine Technology: